Today: 11 June 2026
Browse Category

LSE:FRMI 14 December 2025 - 14 May 2026

Fermi Inc. (FRMI) Board Tightens Rules as Founder Fight Hits Earnings Day

Fermi Inc. (FRMI) Board Tightens Rules as Founder Fight Hits Earnings Day

Fermi Inc.’s board raised the shareholder vote threshold to 70% for key bylaw changes, complicating efforts by ousted co-founder Toby Neugebauer to reshape the board, according to a regulatory filing. The company rejected Neugebauer’s push for a special meeting and board overhaul, while his group seeks support for another meeting by late June. The changes took effect May 13.
14 May 2026
··
Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Fermi shares jumped 9.8% to $9.53 midday Tuesday after a securities-fraud class action was filed in New York, alleging the company overstated tenant demand for its Texas campus. The suit follows a December disclosure that a key tenant terminated a $150 million commitment, which sent shares down 33.8%. Investors have until March 6 to seek lead-plaintiff status. Fermi stock remains well below its $21 IPO price.
6 January 2026
··
Fermi Inc (NASDAQ: FRMI) Stock News on Dec. 24, 2025: New 52-Week Low, Project Matador Tenant Fallout, and Analyst Price Targets

Fermi Inc (NASDAQ: FRMI) Stock News on Dec. 24, 2025: New 52-Week Low, Project Matador Tenant Fallout, and Analyst Price Targets

Fermi Inc (NASDAQ: FRMI) hit a new 52-week low of $7.83 on December 24, closing near $8.04 after losing a $150 million construction funding deal for its Project Matador. Shares plunged 34% on December 12 after the prospective tenant terminated the agreement, leaving the stock far below its $21 IPO price. Trading volume reached about 1.18 million shares.
24 December 2025
·
Fermi Inc (FRMI) Stock Today, Dec. 23, 2025: Tenant Funding Deal Fallout, Amazon Rumor Denial, and What Analysts Forecast Next

Fermi Inc (FRMI) Stock Today, Dec. 23, 2025: Tenant Funding Deal Fallout, Amazon Rumor Denial, and What Analysts Forecast Next

Fermi Inc. shares fell into the mid-$8 range on December 23 after a prospective anchor tenant terminated a $150 million construction-funding agreement for its Texas Project Matador campus. Business Insider reported Amazon was the tenant, but Fermi denied this to Reuters. No funds had been drawn under the agreement. Fermi says lease negotiations with the tenant are ongoing.
23 December 2025
··
Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc shares closed at $8.34 on Dec. 18, down 7.98%, following a volatile week after its $150 million construction funding deal for Project Matador was terminated with no funds drawn. The stock plunged 33.84% on Dec. 12 after the announcement. Business Insider reported Amazon was the withdrawn tenant, but Fermi and its CEO denied the claim to Reuters.
18 December 2025
··
Fermi Inc (FRMI) Stock News Today: Why Shares Are Swinging, Latest SEC Filing, and Analyst Price Targets (Dec. 17, 2025)

Fermi Inc (FRMI) Stock News Today: Why Shares Are Swinging, Latest SEC Filing, and Analyst Price Targets (Dec. 17, 2025)

Fermi Inc. shares fell about 9% to $8.85 Wednesday afternoon after a prospective anchor tenant for its Project Matador in Texas terminated an agreement that could have advanced up to $150 million for construction. Trading volume neared 4.25 million shares. The company disclosed the development in a December 12 SEC filing. Lease negotiations with the tenant are ongoing.
17 December 2025
·
Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. shares dropped 33.8% to $10.09 after a prospective tenant canceled a $150 million construction funding deal for Project Matador in Texas. No funds were drawn before termination. Lease negotiations with the tenant continue. At least one analyst cut its price target to $20, while consensus targets remain in the low $30s.
14 December 2025
··

Stock Market Today

  • US Stocks Rise on AI Gains as Oil Prices Steady Amid Iran War Concerns
    June 11, 2026, 10:56 AM EDT. US stock indices climbed on Thursday, led by artificial intelligence (AI) stocks driving gains in chipmakers like Marvell Technology (+4.3%) and Intel (+10.4%). The S&P 500 rose 0.6%, with the Nasdaq up 0.8% and the Dow gaining 0.7%. Despite escalating tensions in the Iran war, oil prices held steady, with Brent crude easing 1.1% to $92.08 per barrel and U.S. crude down 0.6% to $89.52. The market showed resilience despite concerns over inflation pressures fueled by higher wholesale prices and renewed geopolitical risks. Oracle fell 10.3% after announcing substantial planned borrowing and equity sales to fund AI investments, reflecting investor caution on aggressive spending amidst uncertainty.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Go toTop